Cilengitide in Treating Patients With Acute Myeloid Leukemia
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying how well cilengitide works in treating patients
with acute myeloid leukemia. Cilengitide may stop the growth of cancer cells by blocking the
enzymes necessary for their growth